Abstract While in vitro liver tissue engineering has been increasingly studied during the last several years, presently engineered liver tissues lack the bile duct system. The lack of bile drainage not only hinders essential digestive functions of the liver, but also leads to accumulation of bile that is toxic to hepatocytes and known to cause liver cirrhosis. Clearly, generation of bile duct tissue is essential for engineering functional and healthy liver. Differentiation of human induced pluripotent stem cells (iPSCs) to bile duct tissue requires long and/or complex culture conditions, and has been inefficient so far. Towards generating a fully functional liver containing biliary system, we have developed defined and controlled conditions for efficient 2D and 3D bile duct epithelial tissue generation. A marker for multipotent liver progenitor in both adult human liver and ductal plate in human fetal liver, EpCAM, is highly expressed in hepatic spheroids generated from human iPSCs. The EpCAM high hepatic spheroids can, not only efficiently generate a monolayer of biliary epithelial cells (cholangiocytes), in a 2D differentiation condition, but also form functional ductal structures in a 3D condition. Importantly, this EpCAM high spheroid based biliary tissue generation is significantly faster than other existing methods and does not require cell sorting. In addition, we show that a knock-in CK7 reporter human iPSC line generated by CRISPR/Cas9 genome editing technology greatly facilitates the analysis of biliary differentiation. This new ductal differentiation method will provide a more efficient method of obtaining bile duct cells and tissues, which may facilitate engineering of complete and functional liver tissue in the future.
Introduction
Cholangiocytes are the ductal epithelial cells coating bile duct system in liver, which collect and deliver bile to the gallbladder or small intestine [1] . During liver development and in post-natal livers, ductal epithelial cells have been believed to be differentiated from hepatoblasts or bi-potent liver progenitor cells, which give rise to both hepatocytes and ductal cells [2, 3] . These bi-potent progenitors have been reported to express some cholangiocytes markers [4, 5] . Even though cholangiocytes comprise only a small proportion (3 to 5 %) of liver cells [6] , they play vital roles in a variety of liver diseases, including primary biliary cirrhosis, primary sclerosing cholangitis, liver cancer and alcoholic liver disease [7] . Over the recent several years, there has been significant improvement in generation of functional hepatocytes from human induced pluripotent stem cells (iPSCs) [8] [9] [10] , to establish highly human relevant liver disease models. However, it is still challenging to efficiently generate biliary epithelial cells/tissues from human stem cells, preventing human iPSC based disease modeling and pathogenesis study of many biliary diseases. Here, we report efficient generation of biliary cells and structures in a controlled manner from human pluripotent stem cells. A bipotent liver progenitor marker, EpCAM [11] [12] [13] , is highly expressed in hepatic spheroids derived from human iPSCs (Figs. 1, 2, and 4) . The EpCAM high hepatic spheroids could efficiently generate a monolayer of biliary epithelial cells, in a 2D differentiation condition (Figs. 2 and 4), and could form functional ductal structures in a 3D differentiation condition (Figs. 3 and 4) . Importantly, this biliary tissue generation can be performed not only in a simple and controlled manner, but also with high efficiency and speed compared to other existing methods [14] [15] [16] . This Fig. 1 Generation of EpCAM high hepatic spheroids from human PSCs. a A schematic diagram of ductal differentiation procedure. b Human iPSC derived hepatic spheroids. The human iPSC were differentiated into definitive endoderm (DE) and hepatic progenitor (HP) stage cells, and were subsequently cultured in a low-attachment culture dish for 3 to 5 days with CHIR99021, SB431542 and nicotinamide to support hepatic spheroid formation. c, d These hepatic spheroids expressed significantly higher levels of EpCAM, a bipotent liver progenitor marker, compared to other differentiation stages by both protein and gene analyses (see Fig. 2 ). The hepatic spheroids also expressed AFP, a hepatoblast marker. d Flow cytometric analysis shows the hepatic spheroids are enriched with exclusively EpCAM high cells. Scale Bar, 100 μm human stem cell based biliary differentiation method will provide a better resource for biliary/liver disease modeling and allow more complete and functional liver tissue engineering in the future.
Materials
This study was performed in accordance with the Johns Hopkins Intuitional Stem Cell Research Oversight regulations and followed protocols approved by the Johns Hopkins Institutional Review Board.
Human Induced Pluripotent Stem Cell (iPSC) Lines
The human iPSC lines used in this study were previously generated from diverse healthy donor tissues [17] [18] [19] . To further investigate the ductal cells differentiation process, we generated a CK7-mCherry reporter iPSC line by CRISPR/ Fig. 2 Generation of ductal epithelial cells in a 2D culture condition. a Immunofluorescence analyses of bile duct epithelial cells in a 2D differentiation culture of human iPSC-derived hepatic spheroids. When the hepatic spheroids were further attached to a regular cell culture dish for 5 or more days in EGF containing media, they were induced into monolayers of biliary epithelial cells with high (over 90 %) efficiency. These cells expressed multiple bile duct cell markers. b Real-time PCR analysis of ductal cell marker genes and genes associated with ductal cell commitment, for each stage of ductal differentiation from undifferentiated human iPSCs. These data suggest that the human iPSC-derived hepatic spheroids efficiently differentiate into bile ductal epithelial cells in a defined 2D differentiation condition. DE: definitive endoderm cells derived from human iPSC/ESC, HP: hepatic progenitor cells derived from human iPSC/ESC, Scale Bar, 100 μm. *: p < 0.05, **: p < 0.01 Cas9-mediated homologous recombination (Fig. 4 ). All these iPSC lines are cultured in a feeder free condition (mTeSR1 medium and Matrigel coated plates). To determine the secretory function of differentiated 3D ductal structures, we incubated the ductal cysts with rhodamine123, which can be secreted into the luminal space by MDR, an ATP-dependent transmembrane export pump. The fluorescence intensity inside of the ductal cysts was much higher than the surroundings, which demonstrated that rhodamine123 was successfully transported into luminal space by ductal cells. In addition, this effect can be inhibited by verapamil, an MDR inhibitor. These data demonstrate that the iPSC-derived ductal structures in a 3D condition resemble characteristics and functionality of bile duct tissue in vivo. (Fig. 1a) . These data not only confirm our 2D/3D ductal differentiation protocols but also provide a great resource for kinetic or imaging studies of human bile duct development. Scale Bar, 100 μm 
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Methods

Matrigel Coating of 12 Well Plates for Pluripotent Stem Cell Culture
The whole procedure should be performed under extra aseptic condition.
1)
Thaw frozen Matrigel overnight at 4°C. Prepare 1:4 dilution of Matrigel with chilled DMEM/F12. Prepare 5 ml aliquots using chilled pipettes and freeze them at −20°C. 2) Thaw one 5 ml aliquot on ice.
3) Transfer the thawed aliquot to cold 500 ml DMEM/F-12 medium, mix well and keep on ice. 4) Add 1 ml/well diluted Matrigel into 12 well plates using chilled pipettes. Wrap the coated plates using aluminum foil and incubate at room temperature for 1 h. Store in 4°C (see Note 1). 5) When the plate is ready for iPSC culture, bring the plate to room temperature. 6) Remove the Matrigel solution. Ensure that the coated surface is not scratched by pipette. 7) Immediately add 0.5 ml/well iPSC culture medium and then plate cells.
Human iPSC Culture and Hepatic Spheroid Formation
Human iPSC Culture
Thaw iPSCs lines onto Matrigel coated 12 well plates (see Note 2) . Culture the cells in mTeSR1 medium at 37°C with 5 % CO 2 . Observe the morphology of the colonies under the microscope and change medium every day. When the colonies are large and ready to merge, passage the cells with Accutase or Collagenase IV (see Note 3).
Differentiation of Human iPSCs to EpCAM High Hepatic Spheroids (Fig. 1) It is important that the iPSC colonies be evenly distributed and reach 50-80 % confluence before starting differentiation. Prior to induction of spheroids formation, the human iPSC/ESCs were differentiated into definitive endoderm and hepatic stem/progenitor cells as previously described [10, [17] [18] [19] [20] [21] [22] .
1) Day 0: Replace iPSC culture medium with warm RPMI medium supplemented with 50-100 ng/ml Activin A and 1-2 μM CHIR99021 (see Note 4) . Incubate the cells at 37°C with 5 % CO 2 . 2) Day 1-4/5: Continue replacing the previous culture medium with fresh RPMI supplemented with 50-100 ng/ml Activin A and 0.05-2 % B27 daily (see Note 5) . After day 4, more than 90 % of the cells express definitive endoderm (DE) markers like Sox17 and CXCR4. 3) Day 4-9/10: Change medium to RPMI supplemented with 0.1-1 % B27, 10 ng/ml HGF and 10 ng/ml FGF-4 every day. Following HGF/FGF-4 treatment, majority of cells express low degree of EpCAM, a multipotent hepatic progenitor marker (Fig. 1a, d ). 4) Day 9/10-13/15: Dissociate the d9/10 hepatic progenitor cells with Accutase and replate them in a low-attachment culture dish. Change medium to HSCM supplemented with 10 ng/ml HGF. Within 3~5 days in the lowattachment dish, the hepatic progenitors in suspension culture form hepatic spheroids (Fig. 1b) . At culture day 13-15, over 90 % of hepatic spheroids express high level of EpCAM (Fig. 1d) .
Ductal Differentiation in Defined 2D and 3D Conditions
Cholangiocyte Differentiation in a 2D Condition 1) Approximately 3 to 5 days after suspension culture of hepatic spheroids (3.2.2), replate the spheroids in a regular cell culture dish to induce attachment as a monolayer (see Note 6) . Change medium to BDM containing 20 ng/ml EGF and 10 ng/ml HGF [23] . 2) Continue culturing in the BDM for 5 days. By day 18 to 20, over 90 % of the adherent cells express multiple cholangiocyte markers, including CK7, CK19, SOX9, SCTR, ASBT, AE2, AQP1 and Acetyl-alpha-tubulin as well as cystic fibrosis transmembrane conductance regulator (CFTR), a mature and functional cholangiocyte marker [24] (Fig. 2) . To analyze the expression of biliary epithelial cell specific genes and proteins, harvest the cells for real-time PCR, flow cytometry and perform immunestaining in culture dish (step 3.4).
Ductal Structure Formation in 3D Conditions
To induce functional ductal structures such as ductal cysts and tubes, hepatic spheroids can be cultured in thick Matrigel. 2) Culture the cells in 3D gels in EGF and HGF containing BDM for 5 to 10 days to form ductal structures (Fig. 3a, b) . By day 20, the replated cells in thick Matrigel will form ductal cysts which express multiple ductal cell markers and transport function of bile ducts (Fig. 3c) . 
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